Showing results (1-10 of 1,086) with videos related to

Sort By:
Pageof 109
Gerontology|September 16, 2009
Inflammation and anti-inflammatory strategies for Alzheimer's disease--a mini-reviewBenjamin Brian Alexander McNaull, Stephen Todd, Bernadette McGuinness, et al.
Neuroscience Letters|August 4, 2010
Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementiaBernadette McGuinness, Robyn Carson, Suzanne Lucia Barrett, et al.
Age and Ageing|January 21, 2017
Pisa syndrome due to donepezil: pharmacokinetic interactions to blame?David Pollock, Emma Cunningham, Bernadette McGuinness, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Predicting conversion to dementia in a memory clinic: A standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtypingBernadette McGuinness, Suzanne L Barrett, John McIlvenna, et al.
International Journal of Geriatric Psychiatry|June 8, 2012
The development of effective biomarkers for Alzheimer's disease: a reviewMark S Henry, Anthony P Passmore, Stephen Todd, et al.
The Cochrane Database of Systematic Reviews|June 4, 2013
Rivastigmine for vascular cognitive impairmentJacqueline Birks, Bernadette McGuinness, David Craig
The Cochrane Database of Systematic Reviews|October 13, 2009
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaBernadette McGuinness, Stephen Todd, Peter Passmore, et al.
The Cochrane Database of Systematic Reviews|April 17, 2009
Statins for the prevention of dementiaBernadette McGuinness, David Craig, Roger Bullock, et al.
The Cochrane Database of Systematic Reviews|January 5, 2016
Statins for the prevention of dementiaBernadette McGuinness, David Craig, Roger Bullock, et al.
The Cochrane Database of Systematic Reviews|July 9, 2014
Statins for the treatment of dementiaBernadette McGuinness, David Craig, Roger Bullock, et al.
Pageof 109